Help Therapeutics Co., Ltd.
Clinical trials sponsored by Help Therapeutics Co., Ltd., explained in plain language.
-
Stem cell injection during bypass surgery aims to repair damaged hearts
Disease control Not yet recruitingThis early-stage study tests a new treatment called HiCM-188, made from stem cells that become heart muscle cells. It is given as a single injection into the heart during bypass surgery in 12 adults with severe heart failure. The main goal is to check safety and see if it improve…
Phase: PHASE1, PHASE2 • Sponsor: HELP Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Stem cell patch aims to mend broken hearts in landmark trial
Disease control Not yet recruitingThis early-stage trial tests whether a patch loaded with lab-grown heart muscle cells can help repair damaged heart tissue. Sixteen people with severe heart failure who are already scheduled for bypass surgery will receive either the stem cell patch or a blank patch during their …
Phase: PHASE1, PHASE2 • Sponsor: HELP Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC